A four-year naturalistic prospective study of cardiometabolic disease in antipsychotic-treated patients.
Mackin
P
P
Academic Psychiatry, Institute of Neuroscience, Newcastle General Hospital, Newcastle University, Westgate Road, Newcastle upon Tyne NE4 6BE, United Kingdom. paul.mackin@ncl.ac.uk
Waton
T
T
Watkinson
H M
HM
Gallagher
P
P
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004224:Diterpenes; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D015999:Multivariate Analysis; D011446:Prospective Studies; D012307:Risk Factors
D014150:Antipsychotic Agents; D004224:Diterpenes; D007328:Insulin; D008055:Lipids; C475535:manoyl oxide